Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02414269
Title Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack New York United States Details
Memorial Sloan Kettering Westchester (Consent and Follow-Up) Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (Consent and Follow-Up) New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field